Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.11% | 169.50 | 0.0% | $1483.94m | |
| NVAX | Novavax, Inc. | 2.25% | 212.83 | 80.0% | $625.43m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 3.48% | 8.04 | 0.7% | $562.03m | |
| AMGN | Amgen, Inc. | -0.14% | 258.78 | 1.3% | $554.57m | |
| ILMN | Illumina, Inc. | 1.24% | 403.33 | 3.5% | $501.88m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.41% | 506.48 | 2.7% | $449.94m | |
| GILD | Gilead Sciences, Inc. | 0.62% | 66.79 | 1.0% | $433.53m | |
| BNTX | BioNTech SE | 3.60% | 161.80 | 0.0% | $385.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.18% | 219.76 | 1.9% | $373.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.14% | 168.44 | 2.0% | $372.56m | |
| BIIB | Biogen, Inc. | -1.23% | 269.85 | 1.7% | $244.93m | |
| CRSP | CRISPR Therapeutics AG | 2.68% | 124.93 | 0.6% | $186.56m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.91% | 97.03 | 4.9% | $178.13m | |
| EXAS | EXACT Sciences Corp. | 2.49% | 128.75 | 18.4% | $165.21m | |
| OCGN | Ocugen, Inc. | 17.75% | 6.50 | 0.0% | $162.52m |
Company Profile
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.